TCMS and
Austin Public Health is advising the medical community that the CDC Guidance for Return-to-Work for
Healthcare Personnel was revised April 30, 2020.
As the
CDC continues to compile and analyze the infectivity and transmission of the
COVID-19 virus, new Criteria for Return to Work for Healthcare Personnel with
Confirmed or Suspected COVID-19 (Interim Guidance) have been released.
The
significant changes relate to the change to a “symptom-based strategy” for those with
symptoms and a “time-based
strategy” for those without symptoms.
Additionally,
this guidance extends the
duration of exclusion from work to at least 10 days since symptoms first appeared.
This change was driven by evidence suggesting a longer duration of viral
shedding and hence the concern for possible continued infectivity.
Criteria
for Return to Work is based on the confirmed COVID -19 provider being
symptomatic or asymptomatic.
Symptom-based
strategy
Exclude
from work until
- At least 3 days (72 hours) have passed since recovery:
- Defined as resolution of fever without the use of
fever-reducing medications and
- Improvement in respiratory symptoms (e.g., cough,
shortness of breath); and,
- At least 10 days have passed since symptoms first
appeared
Test-based
strategy
Exclude
from work until:
- Resolution of fever without the use of fever-reducing
medications and
- Improvement in respiratory symptoms (e.g., cough,
shortness of breath), and
Negative results of an FDA Emergency Use
Authorized COVID-19 molecular assay for detection of SARS-CoV-2 RNA from at
least two consecutive nasopharyngeal swab specimens collected ≥24 hours apart
(total of two negative specimens).
Time-based
strategy
Exclude
from work until:
- 10 days have passed since the date of their first
positive COVID-19 diagnostic test assuming they have not subsequently
developed symptoms since their positive test.
- If they develop symptoms, then the symptom-based or
test-based strategy should be used.
Test-based
strategy
Exclude
from work until:
- Negative results of an FDA Emergency Use Authorized
COVID-19 molecular assay for detection of SARS-CoV-2 RNA from at least two
consecutive nasopharyngeal swab specimens collected ≥24 hours apart (total
of two negative specimens).
Regardless
of the strategy employed by a provider, all should continue to self-monitor for
symptoms, and seek re-evaluation from occupational health if respiratory
symptoms recur or worsen.
The
guidance for non-health
care providers to return to work is still seven (7) days from
symptom onset, but must continue to wear cloth face covering or a facemask.
The full
documentation can be found at the CDC Website link below:
https://www.cdc.gov/coronavirus/2019-ncov/hcp/return-to-work.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fhealthcare-facilities%2Fhcp-return-work.html
John
Abikhaled, MD
TCMS President